<DOC>
	<DOC>NCT02988128</DOC>
	<brief_summary>Post market surveillance registry</brief_summary>
	<brief_title>Neurovascular Product Surveillance Registry</brief_title>
	<detailed_description>An observational, prospective, multi-center, single-arm registry to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic Neurovascular market-released products used in the treatment of Intracranial aneurysms.</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements Patient is intended to receive treatment with an eligible product Patient within enrollment window of treatment/therapy received at the time of their initial enrollment. Patient who is, or is expected to be inaccessible for followup Patient with exclusion criteria required by local law Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Embolization Device</keyword>
	<keyword>Flow Diverter</keyword>
	<keyword>Intra saccular device</keyword>
	<keyword>Vascular Reconstruction Device</keyword>
	<keyword>Ruptured Intracranial Aneurysm</keyword>
	<keyword>Unruptured Intracranial Aneurysm</keyword>
</DOC>